Preventing Rh alloimmunization during pregnancy: interpretation of clinical guidelines
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.cn113903-20211113-00948
   		
        
        	
        		- VernacularTitle:预防母胎Rh同种免疫相关指南要点解读
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Lixia SHEN
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Zilian WANG
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 中山大学附属第一医院产科,广州 510080
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Rh isoimmunization;
			        		
			        		
			        		
				        		Rho(D) immune globulin;
			        		
			        		
			        		
				        		Clinical protocols;
			        		
			        		
			        		
				        		Practice guidelines as topic
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Perinatal Medicine
	            		
	            		 2022;25(5):377-379
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Rh alloimmunization can lead to serious fetal complications, such as hemolysis, anemia, edema, and even intrauterine death. However, there is no domestic clinical guideline for prophylaxis and management of Rh alloimmunization. This review aims to interpret the key points from international clinical guidelines, consisting of the timing of routine antibody screening and anti-Rh(D) immunoglobulin prophylaxis strategies for Rh-negative pregnant women, possible sensitization events and anti-D prophylaxis of Rh alloimmunization, and postpartum prophylaxis for unsensitized Rh-negative pregnant women.